Latest news
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Sat, 08 Aug 2026 09:32:14 GMTEli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem - finance.yahoo.comfinance.yahoo.com · Fri, 07 Aug 2026 22:50:00 GMTWeekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development - Fierce HealthcareFierce Healthcare · Fri, 07 Aug 2026 22:00:00 GMTNovo Nordisk makes Omnicom agency of record for US media buying - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:44:19 GMT‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:08:00 GMTNovo Nordisk’s CFO on the oral Wegovy rollout and beyond - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 12:42:20 GMTOmnicom Wins U.S. Media Account for Ozempic and Wegovy Maker Novo Nordisk - ADWEEKADWEEK · Thu, 06 Aug 2026 23:01:06 GMTLilly, Novo defeat antitrust lawsuit over GLP‑1 drug market - ReutersReuters · Thu, 06 Aug 2026 21:52:51 GMT